Allergy, Immunology, and ENT

Latest News

FDA accepts donidalorsen NDA for prophylactic hereditary angioedema | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts donidalorsen NDA for prophylactic hereditary angioedema

November 4th 2024

Application acceptance was based on positive results with monthly and bi-monthly dosing data from a phase 3 trial.

Increasing food allergy incidence in children met with increasing psychology referrals | Image Credit: © tashatuvango - © tashatuvango - stock.adobe.com.
Increasing food allergy incidence in children met with increasing psychology referrals

October 25th 2024

Epinephrine nasal spray now available to treat type I allergic reactions, anaphylaxis | Image Credit: © Saiful52 - © Saiful52 - stock.adobe.com.
Epinephrine nasal spray now available to treat type 1 allergic reactions, anaphylaxis

September 24th 2024

Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP

September 13th 2024

Weekly review: Neffy pre-ordering launches, trofinetide data, and more | Image Credit: © Artur - © Artur - stock.adobe.com.
Weekly review: Neffy pre-ordering launches, trofinetide data, and more

September 6th 2024

© 2024 MJH Life Sciences

All rights reserved.